We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-0.01%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$12.6B
AUM Growth
-$268M
(-2.1%)
Cap. Flow
+$307M
Cap. Flow
% of AUM
2.43%
Top 10 Holdings %
Top 10 Hldgs %
18.04%
Holding
1,230
New
249
Increased
284
Reduced
419
Closed
260
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$292M |
| 2 |
Palo Alto Networks
PANW
|
+$133M |
| 3 |
Booking.com
BKNG
|
+$128M |
| 4 |
O'Reilly Automotive
ORLY
|
+$113M |
| 5 |
Target
TGT
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$162M |
| 2 |
AT&T
T
|
+$158M |
| 3 |
Ford
F
|
+$105M |
| 4 |
Gilead Sciences
GILD
|
+$90.6M |
| 5 |
Prudential Financial
PRU
|
+$88.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.72% |
| 2 | Financials | 14.7% |
| 3 | Healthcare | 14.62% |
| 4 | Consumer Discretionary | 13.76% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITOS
276
DELISTED
iTeos Therapeutics
ITOS
| $8.88M | 0.07% |
+466,325
| New | +$10.7M |
|
277
Organon & Co
OGN
$3.55B
| $8.83M | 0.07% |
377,162
+141,062
| +60% | +$4.26M |
|
278
World Acceptance Corp
WRLD
$880M
| $8.81M | 0.07% |
91,027
+76,432
| +524% | +$8.85M |
|
|
VMEO
279
DELISTED
Vimeo
VMEO
| $8.81M | 0.07% |
2,202,277
+1,322,253
| +150% | +$7.82M |
|
280
NETGEAR
NTGR
$663M
| $8.81M | 0.07% |
439,514
-80,638
| -16% | -$1.81M |
|
281
Apogee Enterprises
APOG
$873M
| $8.77M | 0.07% |
229,573
-63,722
| -22% | -$2.6M |
|
282
Willis Towers Watson
WTW
$29.9B
| $8.75M | 0.07% |
43,543
+26,595
| +157% | +$5.49M |
|
283
8x8 Inc
EGHT
$271M
| $8.7M | 0.07% |
2,521,054
+914,496
| +57% | +$4.37M |
|
284
Karyopharm Therapeutics
KPTI
$161M
| $8.64M | 0.07% |
105,502
+3,699
| +4% | +$276K |
|
285
Autodesk
ADSK
$50.1B
| $8.63M | 0.07% |
46,199
-143,344
| -76% | -$29M |
|
286
StoneX
SNEX
$8.99B
| $8.6M | 0.07% |
524,966
-129,413
| -20% | -$2.21M |
|
287
Employers Holdings
EIG
$912M
| $8.52M | 0.07% |
247,082
-14,049
| -5% | -$551K |
|
288
Axcelis
ACLS
$3.69B
| $8.51M | 0.07% |
+140,572
| New | +$9.08M |
|
289
Healthpeak Properties
DOC
$15.7B
| $8.5M | 0.07% |
370,820
+90,789
| +32% | +$2.4M |
|
290
Vanda Pharmaceuticals
VNDA
$310M
| $8.46M | 0.07% |
855,970
-175,525
| -17% | -$1.85M |
|
291
Titan International
TWI
$530M
| $8.4M | 0.07% |
691,664
+437,102
| +172% | +$6.27M |
|
292
Theravance Biopharma
TBPH
$875M
| $8.39M | 0.07% |
827,906
-31,700
| -4% | -$297K |
|
293
Apple Hospitality REIT
APLE
$3.97B
| $8.35M | 0.07% |
593,815
-671,127
| -53% | -$10.6M |
|
294
Playtika
PLTK
$1.51B
| $8.27M | 0.07% |
+881,179
| New | +$10.2M |
|
295
ProPetro Holding
PUMP
$1.31B
| $8.26M | 0.07% |
+1,026,026
| New | +$9.17M |
|
296
Evolent Health
EVH
$421M
| $8.21M | 0.06% |
+228,455
| New | +$8.05M |
|
297
Hartford Financial Services
HIG
$39.3B
| $8.19M | 0.06% |
132,155
+121,798
| +1,176% | +$7.93M |
|
298
Genworth Financial
GNW
$3.85B
| $8.18M | 0.06% |
2,337,567
-3,644,657
| -61% | -$14.7M |
|
299
Codexis
CDXS
$136M
| $8.05M | 0.06% |
+1,327,668
| New | +$10.7M |
|
300
Lowe's Companies
LOW
$122B
| $8.03M | 0.06% |
42,759
+2,592
| +6% | +$505K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2022 Portfolio in Review
As of Q3 2022, Jacobs Levy Equity Management held 1,230 positions worth $12.6B, down 2.1% from $12.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management's Q3 2022 filing shows 249 new, 284 increased, 419 reduced and 260 closed positions. Its largest new stake was Palo Alto Networks: 1,538,086 shares worth $126M. The largest sale was Alphabet (Google) Class C, an estimated $162M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Jacobs Levy Equity Management's largest Q3 2022 buy was Palo Alto Networks: 1,538,086 shares worth $126M.
- Jacobs Levy Equity Management added most to Tesla in Q3 2022, an estimated $292M increase.
- Jacobs Levy Equity Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $162M.
- Jacobs Levy Equity Management fully exited AT&T in Q3 2022, selling an estimated $158M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $12.6B portfolio in Q3 2022.
- Jacobs Levy Equity Management opened 249 new positions and closed 260 in Q3 2022.
- Jacobs Levy Equity Management's portfolio value fell 2.1% quarter-over-quarter to $12.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2022, filed 15 Nov 2022.